Condition

Angina

ClinicalTrials.gov condition label

Clinical trials15

Recruiting1

Common interventions14

Lead sponsors shown15

Clinical trials

15 shown

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary CareNCT07359287 · 2025-12-01

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart DiseaseNCT05147766 · 2022-02-01

Patient and Provider Assessment of Lipid Management RegistryNCT02341664 · 2015-05-01

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic CardiomyopathyNCT02439541 · 2015-05-01

Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CADNCT01754259 · 2013-04-01

Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes SurveysNCT02032030 · 2012-07-01

Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese PatientsNCT01363193 · 2011-07-01

Tight Hemodynamic Control in Patients Who Are Chronically on MetoprololNCT01404767 · 2011-04-01

Ranolazine and Pulmonary HypertensionNCT01174173 · 2010-06-01

Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study)NCT00824005 · 2009-03-01

Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)NCT00763035 · 2009-01-01

Intravascular Ultrasound Derived Virtual Histology and Intracoronary Serum Markers of InflammationNCT00982852 · 2008-12-01

Body Mass Index and Initial Presentations of Cardiovascular DiseasesNCT01704300 · 2001-01-01

To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mgNCT00946725 · 2000-11-01

Improving Service Delivery Through Access PointsNCT00012623

Common interventions

RanolazineDRUG2 Adult stem cellsBIOLOGICAL1 AlloRxBIOLOGICAL1 Antibiotic prescribing according to guidelinesOTHER1 Atenolol (Tenormin) 100 mg Tablets Zeneca (Astra Zeneca Pharmaceutical)DRUG1 Atenolol 100 mg Tablets (Geneva Pharmaceutical, Inc.)DRUG1 DobutamineDRUG1 EsmololDRUG1 Lean Body Weight-based heparin doseDRUG1 MetoprololDRUG1 PlaceboBIOLOGICAL1 PlaceboDRUG1 RegadenosonDRUG1 UCMSC groupBIOLOGICAL1

Leading sponsors

Affiliated Hospital to Academy of Military Medical Sciences1 Brigham and Women's Hospital1 Duke University1 Nazareth Hospital1 Northwestern University1 Quinn Capers1 Sandoz1 The Foundation for Orthopaedics and Regenerative Medicine1 The University of Texas Health Science Center, Houston1 University College, London1 University Health Network, Toronto1 University Hospital, Caen1 US Department of Veterans Affairs1 Wake Forest University Health Sciences1 Washington University School of Medicine1

Trial status mix

COMPLETED8

TERMINATED4

UNKNOWN2

RECRUITING1

Phase mix

PHASE13

NA2

PHASE22

PHASE32

EARLY_PHASE11

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.